|
|
Volumn 26, Issue 8, 2010, Pages 841-845
|
|
Short communication: Comparable safety and efficacy with once-daily versus twice-daily dosing of lopinavir/ritonavir tablets with emtricitabine + tenofovir DF in antiretroviral-naïve, HIV type 1-infected subjects: 96 week final results of the randomized trial M05-730
a
b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
LOPINAVIR PLUS RITONAVIR;
VIRUS RNA;
ADENINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DEOXYCYTIDINE;
DRUG COMBINATION;
EMTRICITABINE;
LOPINAVIR;
PHOSPHONIC ACID DERIVATIVE;
PYRIMIDINONE DERIVATIVE;
RITONAVIR;
TENOFOVIR;
ADULT;
ANTIVIRAL ACTIVITY;
ANTIVIRAL RESISTANCE;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOSAGE SCHEDULE COMPARISON;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FATIGUE;
FEMALE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HYPERCHOLESTEROLEMIA;
HYPERTRIGLYCERIDEMIA;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
TREATMENT DURATION;
TRIACYLGLYCEROL BLOOD LEVEL;
VIRUS LOAD;
VIRUS MUTATION;
VOMITING;
ANALOGS AND DERIVATIVES;
COMPARATIVE STUDY;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG EFFECTS;
HIV INFECTIONS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
PHASE 3 CLINICAL TRIAL;
VIROLOGY;
ADENINE;
ANTI-HIV AGENTS;
DEOXYCYTIDINE;
DIARRHEA;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
HIV INFECTIONS;
HIV-1;
HUMANS;
PHOSPHONIC ACIDS;
PYRIMIDINONES;
RITONAVIR;
LOPINAVIR;
ORGANOPHOSPHONATES;
|
|
EID: 77955631576
PISSN: 08892229
EISSN: None
Source Type: Journal
DOI: 10.1089/aid.2009.0307 Document Type: Article |
|
Times cited : (18)
|
|
References (10)
|
